Information regarding Coronavirus Disease

News

Dr. Mauricio Cohen, center, performs a procedure in the cardiac catheterization lab. Video & Photo Gallery

Fibrinolytic Therapy for Heart Attacks May Offer Advantages During COVID-19 Pandemic

For patients experiencing an ST-Elevation Myocardial Infarction (STEMI), the medical term for a heart attack, time is muscle. “When a clot closes the coronary artery, the heart muscle starts dying, and patients can experience chest pain and other symptoms,” said Mauricio Cohen, M.D., professor of medicine and director of the Cardiac Catheterization Laboratory at the University of Miami Miller School of Medicine.

Read more about the therapy »

Dr. Daniel Mintz Video & Photo Gallery

Dr. Daniel Mintz, founding scientific director of Diabetes Research Institute, passes away

Scientists, physicians and countless patients mourn the passing of Daniel H. Mintz, M.D., emeritus professor of medicine at the University of Miami Miller School of Medicine and scientific director emeritus of the Diabetes Research Institute.

Read more about Dr. Daniel Mintz »

Miller School Immunologists Identify How Dosing Strategy Improves Effectiveness of Malaria Vaccine

A team of immunology researchers at the University of Miami Miller School of Medicine has uncovered a mechanism of immune protection for the RTS,S/AS01 malaria vaccine that could lead to an effective malaria vaccination program for children.

Read more about the study »

Dr. Ketty Bacallao retrieves stem cells for patient treatment from a liquid nitrogen storage tank.

UM Offers Stem Cells to Treat COVID-19 Patients with Life-Threatening Respiratory Infections

For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal stem cell (MSC) treatments that may help fight the characteristic inflammation that accompanies the viral infection.

Read more about the treatment »

Dr. Maria Luisa Alcaide

UHealth to Offer Convalescent Plasma with COVID-19 Antibodies for Seriously Ill Patients

A new initiative by infectious disease experts and researchers with the University of Miami Health System offers convalescent plasma with COVID-19 antibodies as a treatment for patients who are seriously ill from the coronavirus infection or at serious risk of progression.

Read more about the treatment »

News Archives

Office of the Dean

A message from the dean

Physician News

Read Med News

e-Update

Read e-Update